Compounds > podophyllotoxin
Page last updated: 2024-08-21

podophyllotoxin and triclosan

podophyllotoxin has been researched along with triclosan in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brun, R; Carballeira, NM; Linden, A; O'Neill, R; Perozzo, R; Rüedi, P; Tasdemir, D; Tonge, PJ; Topaloglu, B; Zhang, X1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Brun, R; Carballeira, NM; Herman, R; Kappe, SH; Lauinger, IL; Perozzo, R; Sanabria, D; Tarun, A; Tasdemir, D; Zloh, M1
Belluti, F; Bisi, A; Bolognesi, ML; Brun, R; Cavalli, A; Colizzi, F; Gobbi, S; Kostrewa, D; Lauciello, L; Perozzo, R; Rampa, A; Recanatini, M; Scapozza, L1
Andricopulo, AD; Bwalya, AG; Carballeira, NM; Cordero-Maldonado, ML; Crawford, AD; Guido, RV; Itoe, MA; Kaiser, M; Mota, MM; Tasdemir, D1

Other Studies

5 other study(ies) available for podophyllotoxin and triclosan

ArticleYear
Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli.
    Bioorganic & medicinal chemistry, 2007, Nov-01, Volume: 15, Issue:21

    Topics: Agelas; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; Bacterial Proteins; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Escherichia coli; Marine Biology; Mycobacterium tuberculosis; Plasmodium falciparum; Protozoan Proteins

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.
    Bioorganic & medicinal chemistry, 2010, Nov-01, Volume: 18, Issue:21

    Topics: Alkynes; Antimalarials; Binding Sites; Cell Line, Tumor; Computer Simulation; Erythrocytes; Fatty Acid Synthase, Type II; Fatty Acids, Unsaturated; Humans; Kinetics; Liver; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins

2010
Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI).
    Journal of medicinal chemistry, 2013, Oct-10, Volume: 56, Issue:19

    Topics: Animals; Antimalarials; Cell Line; Coumarins; Crystallography, X-Ray; Drug Design; Drug Resistance, Multiple; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Molecular Docking Simulation; Plasmodium falciparum; Protein Binding; Protein Conformation; Structure-Activity Relationship

2013
2-Octadecynoic acid as a dual life stage inhibitor of Plasmodium infections and plasmodial FAS-II enzymes.
    Bioorganic & medicinal chemistry letters, 2014, Sep-01, Volume: 24, Issue:17

    Topics: Animals; Antimalarials; Cell Line, Tumor; Dose-Response Relationship, Drug; Fatty Acid Synthase, Type II; Fatty Acids, Unsaturated; Humans; Malaria; Models, Molecular; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship; Zebrafish

2014